Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Colitis, Ulcerative × Adalimumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Colitis, Ulcerative 1

Interventions

golimumab 1 Infliximab 1 CT-P13 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03011268 2025-05-31

BIOSTOP

Helse Møre og Romsdal HF

Phase NA Completed

Colitis, Ulcerative, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡